- Home
- HSII vs ABCL Comparison
HSII vs ABCL Comparison
Compare HSII & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSII
- ABCL
- Stock Information
- Founded
- HSII 1953
- ABCL 2012
- Country
- HSII United States
- ABCL Canada
- Employees
- HSII N/A
- ABCL N/A
- Industry
- HSII Diversified Commercial Services
- ABCL Biotechnology: Pharmaceutical Preparations
- Sector
- HSII Consumer Discretionary
- ABCL Health Care
- Exchange
- HSII Nasdaq
- ABCL Nasdaq
- Market Cap
- HSII 904.6M
- ABCL 772.9M
- IPO Year
- HSII 1999
- ABCL 2020
- Fundamental
- Price
- HSII $46.50
- ABCL $3.48
- Analyst Decision
- HSII Buy
- ABCL Strong Buy
- Analyst Count
- HSII 2
- ABCL 4
- Target Price
- HSII $49.00
- ABCL $8.33
- AVG Volume (30 Days)
- HSII 131.5K
- ABCL 7.8M
- Earning Date
- HSII 07-28-2025
- ABCL 08-05-2025
- Dividend Yield
- HSII 1.31%
- ABCL N/A
- EPS Growth
- HSII N/A
- ABCL N/A
- EPS
- HSII 0.37
- ABCL N/A
- Revenue
- HSII $1,116,954,000.00
- ABCL $23,114,000.00
- Revenue This Year
- HSII $6.41
- ABCL N/A
- Revenue Next Year
- HSII $2.65
- ABCL $67.99
- P/E Ratio
- HSII $124.59
- ABCL N/A
- Revenue Growth
- HSII 6.10
- ABCL N/A
- 52 Week Low
- HSII $30.20
- ABCL $1.89
- 52 Week High
- HSII $49.02
- ABCL $4.09
- Technical
- Relative Strength Index (RSI)
- HSII 73.00
- ABCL 60.83
- Support Level
- HSII $43.25
- ABCL $3.22
- Resistance Level
- HSII $44.23
- ABCL $4.09
- Average True Range (ATR)
- HSII 1.02
- ABCL 0.30
- MACD
- HSII 0.20
- ABCL 0.00
- Stochastic Oscillator
- HSII 91.45
- ABCL 34.84
About HSII Heidrick & Struggles International Inc.
Heidrick & Struggles International Inc is a leadership advisory firm providing executive search and consulting services to businesses and business leaders world wide. The company's operating segments include the executive search business which operates in the Americas; Europe; Asia Pacific and On-Demand Talent and Heidrick Consulting. It generates maximum revenue from the Americas.
About ABCL AbCellera Biologics Inc.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.